Johns Hopkins University
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 9, 2024), Johns Hopkins University reported 16 stock positions worth $2.5 billion. Its top holding was iShares MSCI Acwi ETF (ACWI) at 26.6% of the portfolio, followed by iShares 1-5Y Inv Grade (IGSB, 18.7%) and Vanguard Long-Term Corp. Bond (VCLT, 16.0%). Compared with Q1 2024, it opened 1 new position, sold out of 2, added to 3 and reduced 6. The biggest buy was iShares MSCI Acwi ETF (ACWI, shares +16%) and the biggest sale Vanguard Int-Term Corporate (VCIT, shares −20%).
- Most Recent 13F
- Q2 2026
- Location
- BALTIMORE, MD
- CIK
- 0001764756
- Portfolio Value
- $2.5B (Q2 2024)
- SEC Filing
- 0001764756-24-000007 ↗ filed Aug 9, 2024
Holdings Value
Holdings 16 stocks · $2.5B
| ACWI iShares MSCI Acwi ETF | 26.64% | 5,935,538 | $667.2M | Add +15.5% |
| IGSB iShares 1-5Y Inv Grade Corp. | 18.68% | 9,130,559 | $467.9M | Reduce -4.2% |
| VCLT Vanguard Long-Term Corp. Bond | 16.02% | 5,290,374 | $401.3M | Add +1.0% |
| VCIT Vanguard Int-Term Corporate | 14.96% | 4,687,473 | $374.7M | Reduce -20.3% |
| TLH iShares 10-20 Year Treasury | 4.41% | 1,075,427 | $110.4M | Add +4.9% |
| IWD iShares Russell 1000 Value E | 4.34% | 623,115 | $108.7M | No change |
| IWM iShares Russell 2000 ETF | 4.07% | 502,673 | $102.0M | Reduce -32.8% |
| XOP SS SPDR S&P Og Exp & Prod | 2.64% | 454,399 | $66.1M | No change |
| IWB iShares Russell 1000 ETF | 1.92% | 161,370 | $48.0M | No change |
| XBI SS SPDR S&P Biotech ETF | 1.68% | 453,433 | $42.0M | Reduce -0.1% |
| IBB iShares Biotechnology ETF | 1.26% | 229,449 | $31.5M | Reduce -0.1% |
| EEM iShares MSCI Emerging Market | 1.21% | 711,296 | $30.3M | No change |
| IWO iShares Russell 2000 Growth | 1.08% | 103,080 | $27.1M | New |
| IEF iShares 7-10 Year Treasury B | 1.07% | 286,376 | $26.8M | No change |
| VTI VG Morningstar TS MKT ETF-US | 0.01% | 1,293 | $346K | Reduce -5.7% |
| BRNS Barinthus Biotherapeutics PL | 0.01% | 122,237 | $171K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| VCIT Vanguard Int-Term Corporate | Reduce -20.3% | 14.96% | −3.50 |
| IWM iShares Russell 2000 ETF | Reduce -32.8% | 4.07% | −2.05 |
| IGSB iShares 1-5Y Inv Grade Corp. | Reduce -4.2% | 18.68% | −0.36 |
| COIN Coinbase Global Inc. Class A | Sold out | 0.00% | −0.12 |
| IGV iShares Expanded Tech-Softwa | Sold out | 0.00% | −0.02 |
| VTI VG Morningstar TS MKT ETF-US | Reduce -5.7% | 0.01% | −0.00 |
| XBI SS SPDR S&P Biotech ETF | Reduce -0.1% | 1.68% | +0.00 |
| IBB iShares Biotechnology ETF | Reduce -0.1% | 1.26% | +0.03 |
Portfolio Buys Q1 2024 → Q2 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 18 | $1.5B | AGG, QQQ, EMXC, IWB, GNR |
| Q1 2026 | 13 | $1.4B | AGG, QQQ, GNR, EMXC, IWB |
| Q4 2025 | 14 | $1.4B | AGG, QQQ, EMXC, IWB, GNR |
| Q3 2025 | 16 | $1.8B | AGG, QQQ, IWB, EMXC, GNR |
| Q2 2025 | 19 | $1.9B | AGG, QQQ, EMXC, IWB, GNR |
| Q1 2025 | 15 | $2.7B | AGG, ACWI, IWB, IWD, EFV |
| Q4 2024 | 14 | $2.7B | AGG, ACWI, IWD, IWB, VGSH |
| Q3 2024 | 14 | $2.7B | ACWI, IGSB, VCIT, IWD, IWB |
| Q2 2024 | 16 | $2.5B | ACWI, IGSB, VCLT, VCIT, TLH |
| Q1 2024 | 17 | $2.6B | ACWI, IGSB, VCIT, VCLT, IWM |